Evofem Biosciences, Inc. (EVFM)
OTCMKTS · Delayed Price · Currency is USD
0.0060
-0.0007 (-10.45%)
At close: May 5, 2026
Evofem Biosciences Earnings Call Transcripts
Fiscal Year 2025
-
Innovative women's health solutions are driving a strategic partnership focused on global impact and growth. Addressing a restrictive senior creditor is the key challenge before further capital and shareholder actions can proceed. Regular updates and mission-driven leadership underpin the outlook.